Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas

Neoplasia

Volumn 13, Issue 10, 2011, Pages 923-930

  Fendrich, Volker ^a,b   Oh, Edwin ^a,c   Bang, Seungmin ^a   Karikari, Collins ^a   Ottenhof, Niki ^a   Bisht, Savita ^a,d   Lauth, Matthias ^b   Brossart, Peter ^d   Katsanis, Nicholas ^a,c   Maitra, Anirban ^a   Feldmann, Georg ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; PANCREATIC ELASTASE; SONIC HEDGEHOG PROTEIN; TAMOXIFEN;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL ACTIVITY; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL INTERACTION; CONTROLLED STUDY; DISEASE COURSE; EUKARYOTIC FLAGELLUM; GENE MUTATION; INTRACELLULAR SIGNALING; MESENCHYME CELL; NONHUMAN; ONCOGENE; ONCOGENE KRAS; PANCREAS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; STROMA CELL; TRANSGENIC MOUSE;

EID: 80054795610     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11088     Document Type: Article

References (52)

1. Maitra A and Hruban RH (2008). Pancreatic cancer. Annu Rev Pathol 3, 157-188.
2. Jemal A, Siegel R, Xu J, and Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277-300.
3. Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, and Haglund C (2005). Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54, 385-387.
4. Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, Yu J, Kayashima T, Souzaki R, Tajiri T, et al. (2010). Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia 12, 807-817.
5. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, et al. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851.
6. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Castillo CF, Yajnik V, Antoniu B, McMahon M, Warshaw AL, et al. (2003). Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856.
7. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C, Jimeno A, et al. (2007). Blockade of Hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67, 2187-2196.
8. Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, et al. (2008). Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 57, 1420-1430.
9. Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, Alvarez H, Koorstra JB, Habbe N, Karikari C, Mullendore M, et al. (2008). An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther 7, 2725-2735.
10. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457-1461.
11. Jimeno A, Feldmann G, Suarez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, Garcia-Garcia E, Lopez-Rios F, Matsui W, et al. (2009). A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 8, 310-314.
12. Dai J, Ai K, Du Y, and Chen G (2011). Sonic Hedgehog expression correlates with distant metastasis in pancreatic adenocarcinoma. Pancreas 40, 233-236.
13. Lorusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Chang I, Darbonne WC, et al. (2011). Phase I trial of Hedgehog pathway inhibitor GDC-0449 in patients with refractory, locally-advanced or metastatic solid tumors. Clin Cancer Res 17, 2502-2511.
14. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806.
15. Hidalgo M and Maitra A (2009). The Hedgehog pathway and pancreatic cancer. N Engl J Med 361, 2094-2096.
16. Maitra A (2010). Tracking down the Hedgehog's lair in the pancreas. Gastroenterology 138, 823-825.
17. G12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469-483.
18. Hruban RH, Rustgi AK, Brentnall TA, Tempero MA, Wright CV, and Tuveson DA (2006). Pancreatic cancer in mice and man: the Penn Workshop 2004. Cancer Res 66, 14-17.
19. Fendrich V, Schneider R, Maitra A, Jacobsen ID, Opfermann T, and Bartsch DK (2011). Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. Neoplasia 13, 180-186.
20. Pasca di Magliano M, Sekine S, Ermilov A, Ferris J, Dlugosz AA, and Hebrok M (2006). Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20, 3161-3173.
21. Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran-Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, et al. (2010). Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 138, 1810-1822.
22. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, et al. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450.
23. Desai BM, Oliver-Krasinski J, De Leon DD, Farzad C, Hong N, Leach SD, and Stoffers DA (2007). Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J Clin Invest 117, 971-977.
24. Fendrich V, Esni F, Garay MV, Feldmann G, Habbe N, Jensen JN, Dor Y, Stoffers D, Jensen J, Leach SD, et al. (2008). Hedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology 135, 621-631.
25. Goodrich LV, Milenkovic L, Higgins KM, and Scott MP (1997). Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113.
26. Fendrich V, Waldmann J, Esni F, Ramaswamy A, Mullendore M, Buchholz M, Maitra A, and Feldmann G (2007). Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr Relat Cancer 14, 865-874.
27. Esni F, Stoffers DA, Takeuchi T, and Leach SD (2004). Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas. Mech Dev 121, 15-25.
28. Rohatgi R, Milenkovic L, and Scott MP (2007). Patched1 regulates Hedgehog signaling at the primary cilium. Science 317, 372-376.
29. Chen Y, Yue S, Xie L, Pu XH, Jin T, and Cheng SY (2011). Dual phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium. J Biol Chem 286, 13502-13511.
30. Zhang Y, Laterra J, and Pomper MG (2009). Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia 11, 96-101.
31. Goppner D and Leverkus M (2011). Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease. J Skin Cancer 2011, 650258.
32. Dijkgraaf GJ, Alicke B, Weinmann L, Januario T, West K, Modrusan Z, Burdick D, Goldsmith R, Robarge K, Sutherlin D, et al. (2011). Small molecule inhibition of GDC-0449 refractory Smoothened mutants and downstream mechanisms of drug resistance. Cancer Res 71, 435-444.
33. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, et al. (2009). Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572-574.
34. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, et al. (2009). Treatment of medulloblastoma with Hedgehog pathway inhibitor GDC-0449. N Engl J Med 361, 1173-1178.
35. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, et al. (2009). Inhibition of the Hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361, 1164-1172.
36. Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et al. (2010). Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 102, 340-351.
37. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, and Simeone DM (2007). Identification of pancreatic cancer stem cells. Cancer Res 67, 1030-1037.
38. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al. (2008). A paracrine requirement for Hedgehog signalling in cancer. Nature 455, 406-410.
39. Bailey JM, Mohr AM, and Hollingsworth MA (2009). Sonic Hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28, 3513-3525.
40. Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, and Hollingsworth MA (2008). Sonic Hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 14, 5995-6004.
41. Lauth M, Bergstrom A, Shimokawa T, Tostar U, Jin Q, Fendrich V, Guerra C, Barbacid M, and Toftgard R (2010). DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat Struct Mol Biol 17, 718-725.
42. Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, Fernandez-Zapico ME, and Hanahan D (2009). GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23, 24-36.
43. Mao J, Ligon KL, Rakhlin EY, Thayer SP, Bronson RT, Rowitch D, and McMahon AP (2006). A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 66, 10171-10178.
44. Huangfu D and Anderson KV (2005). Cilia and Hedgehog responsiveness in the mouse. Proc Natl Acad Sci USA 102, 11325-11330.
45. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, and Yoder BK (2005). Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 1, e53.
46. Corbit KC, Aanstad P, Singla V, Norman AR, Stainier DY, and Reiter JF (2005). Vertebrate Smoothened functions at the primary cilium. Nature 437, 1018-1021.
47. Chen MH, Wilson CW, Li YJ, Law KK, Lu CS, Gacayan R, Zhang X, Hui CC, and Chuang PT (2009). Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev 23, 1910-1928.
48. Svard J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, Bergstrom A, Ericson J, Toftgard R, and Teglund S (2006). Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 10, 187-197.
49. Cooper AF, Yu KP, Brueckner M, Brailey LL, Johnson L, McGrath JM, and Bale AE (2005). Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused. Development 132, 4407-4417.
50. Humke EW, Dorn KV, Milenkovic L, Scott MP, and Rohatgi R (2010). The output of Hedgehog signaling is controlled by the dynamic association between suppressor of fused and the Gli proteins. Genes Dev 24, 670-682.
51. Tukachinsky H, Lopez LV, and Salic A (2010). A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol 191, 415-428.
52. Seeley ES, Carriere C, Goetze T, Longnecker DS, and Korc M (2009). Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res 69, 422-430.